tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

Psychedelic: atai Life Sciences reports BPL-003 study results
The FlyPsychedelic: atai Life Sciences reports BPL-003 study results
18h ago
ATAI
CMND
MindMed Initiates Second Phase 3 Study of MM120 for Anxiety
PremiumCompany Announcements
MindMed Initiates Second Phase 3 Study of MM120 for Anxiety
21h ago
MNMD
Mind Medicine doses first patient in Panorama study
PremiumThe Fly
Mind Medicine doses first patient in Panorama study
24h ago
MNMD
AMD downgraded, Cisco upgraded: Wall Street’s top analyst calls
PremiumThe Fly
AMD downgraded, Cisco upgraded: Wall Street’s top analyst calls
3d ago
TT
AMD
Mind Medicine initiated with an Outperform at Evercore ISI
PremiumThe Fly
Mind Medicine initiated with an Outperform at Evercore ISI
3d ago
MNMD
Rising High: Innovative Industrial reports PharmaCann default
PremiumThe FlyRising High: Innovative Industrial reports PharmaCann default
1M ago
ACB
CGC
Mind Medicine initiated with a Buy at Chardan
Premium
The Fly
Mind Medicine initiated with a Buy at Chardan
1M ago
MNMD
Mind Medicine to be added to Nasdaq Biotechnology Index December 23.
Premium
The Fly
Mind Medicine to be added to Nasdaq Biotechnology Index December 23.
1M ago
MNMD
MindMed Begins Phase 3 LSD Study for Anxiety
PremiumCompany Announcements
MindMed Begins Phase 3 LSD Study for Anxiety
2M ago
MNMD
Mind Med: First patient dosed in Voyage study of LSD in treatment of GAD
PremiumThe Fly
Mind Med: First patient dosed in Voyage study of LSD in treatment of GAD
2M ago
MNMD
Rising High: Cannabis firms report quarterly earnings
PremiumThe Fly
Rising High: Cannabis firms report quarterly earnings
2M ago
ACB
CGC
Mind Medicine awarded innovation passport designation by UK to treat GAD
PremiumThe Fly
Mind Medicine awarded innovation passport designation by UK to treat GAD
2M ago
MNMD
MindMed call volume above normal and directionally bullish
PremiumThe FlyMindMed call volume above normal and directionally bullish
2M ago
MNMD
MindMed Appoints New Chief to Boost Drug Approvals
Premium
Company Announcements
MindMed Appoints New Chief to Boost Drug Approvals
2M ago
MNMD
Mind Medicine appoints Gregg Pratt chief regulatory, quality assurance officer
Premium
The Fly
Mind Medicine appoints Gregg Pratt chief regulatory, quality assurance officer
2M ago
MNMD
Unusually active option classes on open November 15th
PremiumThe Fly
Unusually active option classes on open November 15th
3M ago
MQ
PCT
Mind Medicine Set to Engage at Key Investor Conferences
PremiumCompany Announcements
Mind Medicine Set to Engage at Key Investor Conferences
3M ago
MNMD
Mind Medicine price target raised to $16 from $14 at Canaccord
PremiumThe Fly
Mind Medicine price target raised to $16 from $14 at Canaccord
3M ago
MNMD
MindMed Advances Phase 3 Trials in Mental Health
PremiumCompany Announcements
MindMed Advances Phase 3 Trials in Mental Health
3M ago
MNMD
Mind Medicine’s Financial Health and Phase 3 Progress
PremiumCompany AnnouncementsMind Medicine’s Financial Health and Phase 3 Progress
3M ago
MNMD
Mind Medicine reports Q3 EPS (27c) , consensus (28c)
Premium
The Fly
Mind Medicine reports Q3 EPS (27c) , consensus (28c)
3M ago
MNMD
Mind Medicine assumed with an Outperform at Leerink
Premium
The Fly
Mind Medicine assumed with an Outperform at Leerink
4M ago
MNMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >